Target intelligence / Profile preview

Ubiquitin carboxyl-terminal hydrolase 4, pseudogene

Molecular classification
Other, Pseudogene
01

Overview

Ubiquitin carboxyl-terminal hydrolase 4, pseudogene (ENSG00000267587) is annotated in genomic databases as a human pseudogene related by sequence to the ubiquitin carboxyl-terminal hydrolase family, particularly the functional gene USP4 (ubiquitin specific peptidase 4). Pseudogenes arise from gene duplication or retrotransposition events but acquire mutations that prevent them from encoding functional proteins. This particular locus does not produce a functional enzyme, nor has it been implicated as a drug target, signaling molecule, or biomarker. It is generally excluded from discussions of receptors, transporters, enzymes, or other conventional therapeutic targets because it does not encode a protein product. Given that Ubiquitin carboxyl-terminal hydrolase 4, pseudogene is a pseudogene and not a protein-coding gene, there is something "incorrect" about treating it as a molecular drug target or functional receptor. No drugs, mechanisms of action, safety considerations, or molecular functions are associated with this entry, and it should not be included in target-based drug discovery workflows. If you intended to reference the functional enzyme (USP4 or Ubiquitin carboxyl-terminal hydrolase 4), a correction is needed; otherwise, no further structured therapeutic information can be retrieved for this pseudogene entry.

Beyond the preview

Go deeper on Ubiquitin carboxyl-terminal hydrolase 4, pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin carboxyl-terminal hydrolase 4, pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call